Interleukin-1β and interleukin-6 gene polymorphisms in Egyptian sickle cell disease patients
Abstract Background Sickle cell disease (SCD) is a disorder characterized by a heterogeneous clinical outcome. Interleukin-1β (IL-1β) and interleukin-6 (IL-6) are important mediators of inflammatory response. Genetic modifiers that alter cytokine levels may contribute to the clinical variability of...
Main Authors: | Yasmine Elammary, Nadia Sewelam, Hanan Al-Wakeel, Mona El-Ghamrawy, Shahira Zayed |
---|---|
Format: | Article |
Language: | English |
Published: |
SpringerOpen
2020-05-01
|
Series: | Egyptian Pediatric Association Gazette |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s43054-020-00025-z |
Similar Items
-
Association between Interleukin-6 Promoter Polymorphism (-174 G/C), Serum Interleukin-6 Levels and Mortality in Severe Septic Patients
by: Leonardo Lorente, et al.
Published: (2016-11-01) -
Study of the effect of interleukin-6 gene polymorphism in patients with rheumatoid arthritis
by: Marwa H Sedira, et al.
Published: (2019-01-01) -
The association between interleukin 6 −174 G/C gene polymorphism and the risk of osteoporosis: A meta-analysis
by: Jonny K. Fajar, MD, et al.
Published: (2017-06-01) -
Relationship Between Interleukin-6 −174G/C Genetic Variant and Efficacy of Methotrexate Treatment in Psoriatic Arthritis Patients
by: Sokolik R, et al.
Published: (2021-01-01) -
Cytokine gene polymorphism in type 2 diabetes mellitus in the Europeoid women of Russia
by: V I Konenkov, et al.
Published: (2012-10-01)